HighTower Advisors LLC Lowers Stock Position in Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

HighTower Advisors LLC trimmed its stake in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 45.9% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 2,704 shares of the company’s stock after selling 2,298 shares during the period. HighTower Advisors LLC’s holdings in Invesco Pharmaceuticals ETF were worth $235,000 as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in the stock. International Assets Investment Management LLC purchased a new stake in shares of Invesco Pharmaceuticals ETF in the 2nd quarter valued at $66,000. Envestnet Asset Management Inc. grew its position in Invesco Pharmaceuticals ETF by 87.7% in the 2nd quarter. Envestnet Asset Management Inc. now owns 23,878 shares of the company’s stock valued at $1,963,000 after acquiring an additional 11,156 shares in the last quarter. Joseph Group Capital Management increased its stake in Invesco Pharmaceuticals ETF by 10.8% during the second quarter. Joseph Group Capital Management now owns 13,001 shares of the company’s stock worth $1,069,000 after purchasing an additional 1,272 shares during the period. Northwestern Mutual Wealth Management Co. lifted its position in shares of Invesco Pharmaceuticals ETF by 49.7% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 6,826 shares of the company’s stock worth $561,000 after purchasing an additional 2,266 shares in the last quarter. Finally, HBW Advisory Services LLC purchased a new position in shares of Invesco Pharmaceuticals ETF in the third quarter valued at approximately $509,000.

Invesco Pharmaceuticals ETF Stock Performance

Shares of PJP stock opened at $83.00 on Wednesday. Invesco Pharmaceuticals ETF has a fifty-two week low of $74.82 and a fifty-two week high of $89.87. The company has a 50 day moving average price of $86.32 and a 200 day moving average price of $85.47. The stock has a market capitalization of $281.37 million, a P/E ratio of 21.48 and a beta of 0.61.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.